Effect of a novel anti-allergic agent, HSR-609, on antigen-induced airway hyperresponsiveness in mice

Pharmacology

Volumn 61, Issue 2, 2000, Pages 70-77

  Musoh, Keiichi ^a   Maeda, Yoshizou ^a   Tanaka, Hiroyuki ^a   Inagaki, Naoki ^a   Nagai, Hiroichi ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Airway hyperresponsiveness; Eosinophil; Histamine; Interleukin 5; Th2

Indexed keywords

3 [4 (8 FLUORO 5,11 DIHYDROBENZ[B]OXEPINO[4,3 B]PYRIDIN 11 YLIDENE)PIPERIDINO]PROPIONIC ACID; ACETYLCHOLINE; ANTIALLERGIC AGENT; CETIRIZINE; INTERLEUKIN 5; PREDNISOLONE; TERFENADINE;

ALLERGY; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; EOSINOPHILIA; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH2 CELL;

EID: 0033839638     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028383     Document Type: Article

References (59)

1. Spry CFJ, Kay AB, Gleich GJ: Eosinophils 1992. Immunol Today 1992;13:384-387.
2. Weller PF: Eosinophils: structure and functions. Curr Opin Immunol 1994;6:85-90.
3. Venge P: The human eosinophil in inflammation. Agents Actions 1990;29:122-126.
4. Cartier A, Thompson NC, Firth PA, Roberts R, Hargreave FE: Allergen-induced increase in bronchial responsiveness to histamine: Relationship to the late asthmatic response and change in airway caliber. J Allergy Clin Immunol 1982;70:170-177.
5. Durham SR, Kay AB: Eosinophils, bronchial hyperreactivity and late phase asthmatic reactions. Clin Allergy 1985;15:411-418.
6. Kapp A: The role of eosinophils in the pathogenesis of atopic dermatitis: Eosinophil granule proteins as markers of disease activity. Allergy 1993;48:1-5.
7. Ott NL, Gleich GJ, Peterson EA, Fujisawa T, Sur S, Leiferman KM: Assessment of eosinophil and neutrophil participation in atopic dermatitis: Comparison with the IgE-mediated late phase reaction. J Allergy Clin Immunol 1994;94:120-128.
8. De Monchy JG, Kauffman HF, Venge P, Koeter GH, Jansen HM, Sluiter HJ, De Vries K: Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 1985;131:373-376.
9. Beasley R, Roche WR, Roberts JA, Holgate ST: Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989;139:806-817.
10. Azzawi M, Bradley B, Jeffery PK, Frew AJ, Wardlaw AJ, Knowles G, Assoufi B, Collins JV, Durham S, Kay AB: Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis 1990;142:1407-1413.
11. Ohashi Y, Motojima S, Fukuda T, Makino S: Airway hyperresponsiveness, increased intracellular spaces of bronchial epithelium, and increased infiltration of eosinophils and lymphocytes in bronchial mucosa in asthma. Am Rev Respir Dis 1992;145:1469-1476.
12. Van Oosterhout AJM, Fattah D, Van Ark I, Hofman G, Buckley TL, Nijkamp FP: Eosinophil infiltration precedes development of airway hyperreactivity and mucosal exudation after intranasal administration of interleukin-5 to mice. J Allergy Clin Immunol 1995;96:104-112.
13. Eum SY, Hailé S, Lefort J, Huerre M, Vargaftig BB:Eosinophil recruitment into the respiratory epithelium following antigenic challenge in hyper-IgE mice is accompanied by interleukin-5-dependent bronchial hyperresponsiveness. Proc Natl Atad Sci USA 1995;92:12290-12294.
14. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG: Interleukin 5 Deficiency abolishes cosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996;183:195-201.
15. Van Oosterhout AJM, Rudolf A, Ladenius C, Savelkoul HFJ, Van Ark I, Delsman KC, Nijkamp FP: Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs. Am Rev Respir Dis 1993;147:548-552.
16. Akutsu I, Kijima T, Kariyone A, Fukuda T, Makino S, Takatsu K: Antibody against interleukin-5 prevents antigen-induced eosinophil infiltration and bronchial hyperreactivity in the guinea pig airway. Immunol Lett 1995;45: 109-116.
17. Mauser PJ, Pitman AM, Fernandez X, Foran SK, Adams III GK, Kreutner W, Egan RW, Chapman RW: Effects of an antibody to interleukin-5 in a monkey model of asthma. Am J Respir Crit Care Med 1995;152:467-472.
18. Walsh GM, Hartnell A, Wardlaw AJ, Kurihara K, Sanderson CJ, Kay AB: IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leukocyte integrin (CD11/18) dependent manner. Immunology 1990;71: 258-265.
19. Yamaguchi Y, Hayashi Y, Sugawa Y, Miura Y, Kasahara T, Kitamura S, Torisu M, Mita S, Tominaga A, Takatsu K, Suda T: Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. J Exp Med 1988;167:1737-1742.
20. Yamaguchi Y, Suda T, Suda J, Eguchi M, Miura Y, Harada N, Tominaga A, Takatsu K: Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J Exp Med 1988;167:43-56.
21. Lopez AF, Sanderson CJ, Gamble JR, Campbell HR, Young IG, Vadas MA: Rccombinant human interleukin-5 is a selective activator of human cosinophil function. J Exp Med 1988; 167:219-224.
22. Nagai H, Yamaguchi S, Inagaki N, Tsuruoka N, Hitoshi Y, Takatsu K: Effect of anti-IL-5 monoclonal antibody on allergic bronchial eosinophilia and airway hyperresponsiveness in mice. Life Sci 1993;53:243-247.
23. Yamaguchi S, Nagai H, Tanaka H, Tsujimoto M, Tsuruoka N: Time course study for antigen-induced airway hyperreactivity and the effect of soluble IL-5 receptor. Life Sci 1994;54:471-475.
24. Nagai H, Yamaguchi S, Maeda Y, Tanaka H: Effect of some immunosupressants on airway hyperreactivity in mice. Int Arch Allergy Immunol 1995;108:189-195.
25. Nagai H, Yamaguchi S, Maeda Y, Tanaka H: Role of mast cells, eosinophils and 1L-5 in the development of airway hyperreactivity in sensitized mice. Clin Exp Allergy 1996;26:642-647.
26. Nagai H, Maeda Y, Tanaka H: The effect of anti-lL-4 monoclonal antibody, rapamycin and interferon-γ on airway hyperreactivity to acetylcholine in mice. Clin Exp Allergy 1996;27: 218-224.
27. Iwasaki N, Ohashi T, Musoh K, Nishino H, Kado N, Kato H, Ito Y: Amphoteric Drugs. 3. Synthesis and anti-allergic activity of 3-[5,11-dihydro[1]benzoxepino[4,3-b]pyridin-11-ylidene)piperidino]propionic acid derivatives and related compounds. J Med Chem 1995;38: 496-507.
28. Musoh K, Ohashi T, Takahashi H, Iwanage Y, Morikawa K, Kato H, Ito Y: Pharmacological studies of HSR-609, a novel amphoteric antiallergic agent (1): Effects on various allergic models. Jpn J Pharmacol 1995;67(suppl): 285P.
29. Kawamura K, Hosotani T, Ohashi T, Kimura T, Watanabe Y, Iwanaga Y, Morikawa K, Kato H, Ito Y, Gomi Y: Pharmacological studies of HSR-609, a novel amphoteric antiallergic agent (2): Organ specificity of antihistamine action. Jpn J Pharmacol 1995;67(suppl):285P.
30. 1-receptor. Jpn J Pharmacol 1997;73:291-298.
31. Kakiuchi M, Ohashi T, Tanaka K, Kamiyama K, Morikawa K, Kato H: Pharmacological studies on the novel antiallergic agent HSR-609: Its effects on behavior in mice and electroencephalograms in rabbits. Jpn J Pharmacol 1996;75:43-57.
32. Kakiuchi M, Ohashi T, Tanaka K, Ohara N, Kamiyama K, Morikawa K, Kato H: Central nervous systems effects on novel antiallergic agent HSR-609 and typical antiallergic agents using behavior and electroencephalographic analyses in dogs. Jpn J Psychopharmacol 1998; 18:189-199.
33. Tasaka K: Anti-allergic drugs. Drugs Today 1986;22:101-133.
34. Cox JSG: Disodium cromoglycate (FPL670) ('Intal'): A specific inhibitor of reaginic antibody-antigen mechanisms. Nature 1967;216: 1328-1329.
35. Ennis M, Truneh A, White JR, Pearce FL: Inhibition of histamine secretion from mast cell. Nature 1981;289:186-187.
36. Koda A, Nagai H, Watanabe S, Yanagihara Y, Sakamoto K: Inhibition of hypersensitivity reactions by a new drug, n-(3′.4′-dimethoxycinnamoyl) anthranilic acid (N-5′). J Allergy Clin Immunol 1976;57:396-407.
37. Martin U, Römer D: The pharmacological properties of a new, orally active antianaphylactic compound: Ketotifen, a benzocycloheptathiophene. Arzneimittel-Forsch 1978;28: 770-782.
38. Katayama S, Akimoto N, Shinoya H, Morimoto T, Katoh Y: Antiallergic effect of azelastine hydrocholide on immediate type hypersensitivity reactions in vivo and in vitro. Arzneimittel-Forsch 1981;31:1196-1203.
39. Cheng HC, Woodward JK: A kinetic study of the antihistaminic effect of terfenadine. Arzneimittel-Forsch 1982;32:1160-1166.
40. 1-receptor antagonist. J Med Chem 1988;41: 853-863.
41. Musoh K, Nakamura N, Sakurai T, Inagaki N, Nagai H: Scratching behavior in mice associated with IgE-mediated allergic cutaneous reaction and its pharmacological characterization. Allergol Int 1997;46:117-124.
42. Konzett H, Rössler R: Versuchsanordnung zu Untersuchungen an der Bronchialmuskulatur. Arch Exp Path Pharmacol 1940;195:71-77.
43. Yamaya H, Basaki Y, Togawa M, Kojima M, Kiniwa M, Matsuura N: Down-regulation of Th2 cell-mediated murine peritoneal eosinophilia by antiallergic agents. Life Sci 1995;56: 1647-1654.
44. Kaye J, Porcelli S, Tite J, Jones B, Janeway CA: Both a monoclonal antibody and antisera specific for determinants unique to individual cloned helper T cell lines can substitute for antigen and antigen-presenting cells in the activation of T cells. J Exp Med 1983;158:836-856.
45. Martins MA, Pasquale CP, éSilva PMR, Pires ALA, Ruffié C, Rihoux JP, Cordeiro RSB, Vargaftig BB: Interference of cetirizine with the late eosinophil accumulation induced by either PAF or compound 48/80. Br J Pharmacol 1992;105:176-180.
46. Gundel RH, Letts LG, Gleich GJ: Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. J Clin Invest 1991;87:1470-1473.
47. Desai SN, Rohson VJ, Letts LG, Gundel RH, Gleich GJ, Piper PJ, Noonan TC: Human eosinophil major basic protein augments bronchoconstriction induced by intravenous agonists in guinea pigs. Agents Actions 1993;39: C132-C135.
48. Uchkla DA, Ackerman SJ, Coyle AJ, Larsen GL, Weller PF, Freed J, Irvin CG: The effect of human eosinophil granule major basic protein on airway responsiveness in rat in vivo: A comparison with polycations. Am Rev Respir Dis 1993;147:982-988.
49. Mauser PJ, Pitman A, Witt A, Fernandez X, Zurcher J, Kung T, Jones H, Watniek AS, Egan RW, Kreutner W, Adams III GK: Inhibitory effect ul TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma. Am Rev Respir Dis 1993;148:1623-1627.
50. Corry DB, Folkesson HG, Warnock ML, Erle DJ, Matthay MA, Wiener-Kronish JP, Locksley RM: Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med 1996; 183:109-117.
51. Miki I, Kusano A, Ohta S, Hanai N, Otoshi M, Masaki S, Sato S, Ohmori K: Histamine enhanced the TNF-α-induccd expression of E-selection and ICAM-1 on vascular endothelial cells. Cell Immunol 1996;171:285-288.
52. Saito H, Shimizu H, Mita H, Maeda Y, Akiyama K: Histamine augments VCAM-1 expression on IL-4 and TNF-α-stimulated human umbilical vein endothelial cells. Int Arch Allergy Immunol 1996;111:126-132.
53. Thorlacius H, Lindbom L, Hedqvist P, Raud J: Microvascular actions of histamine: Synergism with leukotriene B-4 and role in allergic leukocyte recruitment. Clin Exp Allergy 1997;27: 445-451.
54. Weimer LK, Gamache DA, Yanni JM: Histaminc-stimulated cytokine secretion from human conjunctival epithelial cells: Inhibition by the histamine H1 antagonist emedastine. Int Arch Allergy Immunol 1998;115:288-293.
55. Konno S, Asano K, Okamoto K, Adachi M: Inhibition of cytokine production from human peripheral blood leukocytes by anti-allergic agents in vivo. Eur J Pharmacol 1994;264:265-268.
56. Paolieri F, Battifora M, Riccio AM, Bertolini C, Cutolo M, Bloom M, Ciprandi G, Canonica GW, Bagnasco M: Terfenadine and fexofenadine reduce in vitro 1CAM-1 expression on human continuous cell lines. Ann Allergy Asthma Immunol 1998;81:601-607.
57. Sedgwick JB, Busse WW: Inhibitory effect of cetirizine on cytokine-enhanced in vitro eosinophil survival. Ann Allergy Asthma Immunol 1997;78:581-585.
58. Albanesi C, Pastore S, Fanales Belasio E, Girolomoni G: Cetirizine and hydrocortisone differentially regulate ICAM-1 expression and chemokine release in cultured human keratinocytes.Clin Exp Allergy 1998;28;101-109.
59. Hiraoka Y, Oshita M, Hosotani T, Watanabe Y, Musoh K, Ohashi T, Morikawa K, Nagata O, Kato H: Pharmacological characterization of HSR-609, a novel amphoteric antiallergic agent. Jpn J Pharmacol 1998;76(suppl):165P.